Recently Viewed 0
Meet Clearsynth at CPHI Milan · October 6–8, 2026 · Booth 10F24 Book a meeting
My Account Need quick assistance? WhatsApp us +91-22-45045900 sales@clearsynth.com

(3R,4S)-Tofacitinib

In Stock

(3R,4S)-Tofacitinib

Impurity · API Family: Tofacitinib · CAT No. CS-T-62103 · CAS No. 1092578-46-5
Stock Status: In Stock   Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Clearsynth product packaging

Packaging & Handling

Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.

Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.

(3R,4S)-Tofacitinib Product Information

(3R,4S)-Tofacitinib is listed under Impurity and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Tofacitinib. The product is supplied by Clearsynth under CAT No. CS-T-62103.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Technical Data

Product Name
(3R,4S)-Tofacitinib
CAS No.
1092578-46-5
CAT No.
CS-T-62103
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C16H20N6O
Molecular Weight
312.37
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.

Description

Regulatory Description
(3R,4S)-Tofacitinib is supplied with detailed characterization data compliant with regulatory guideline. (3R,4S)-Tofacitinib can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Tofacitinib.
Overview
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
Synonyms
(3R,4S)-Tofacitinib
Application Notes
(3R,4S)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
References

Product Applications & Regulatory Search Terms

Useful product, supplier and regulatory search terms for this reference standard.

Buy 1092578-46-5Purchase 1092578-46-5Order 1092578-46-5Enquire 1092578-46-5Price of 1092578-46-51092578-46-5 Supplier1092578-46-5 Manufacturer1092578-46-5 ExporterBuy high quality (3R,4S)-TofacitinibPurchase (3R,4S)-Tofacitinib(3R,4S)-Tofacitinib Suppliers(3R,4S)-Tofacitinib Manufacturers(3R,4S)-Tofacitinib PriceOrder (3R,4S)-TofacitinibEnquire (3R,4S)-Tofacitinib(3R,4S)-Tofacitinib Cost(3R,4S)-Tofacitinib Supplier(3R,4S)-Tofacitinib Distributor(3R,4S)-Tofacitinib for Method Validation(3R,4S)-Tofacitinib for ANDA Filing(3R,4S)-Tofacitinib for Forced Degradation Studies(3R,4S)-Tofacitinib Identification Standards(3R,4S)-Tofacitinib for DMF FilingTofacitinib Reference Standard
Downloading MSDS…
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.